Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lactoferrin Administration on Rhabdomyolysis-induced Heart and Kidney Injury in Rats

NCT06491394 is registered in ClinicalTrials.gov with Aswan University Hospital as lead sponsor.

NCT NCT06491394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06491394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lactoferrin Administration on Rhabdomyolysis-induced Heart and Kidney Injury in Rats
Lead sponsor
Aswan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2024
Completion date
April 1, 2025
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhabdomyolysis